Abstract
Background/objectives
Body fat distribution has been shown to be a predictor of adhesion molecule and inflammatory marker expression albeit the effect of modest weight change on concentrations of adhesion molecules and inflammatory markers in postmenopausal women are not fully understood. The primary aim was to investigate the effects of weight change on adhesion molecules and inflammatory markers over 24 months in postmenopausal women.
Subjects/methods
Body composition was assessed in 254 healthy postmenopausal women using dual-energy X-ray absorptiometry (DXA). Adhesion molecules and inflammatory markers were analysed by multiplex ELISA. Participants weight gain/loss at 24 months was defined as any value that was either above/below the weight value recorded at baseline.
Results
Postmenopausal women with an average weight loss of 3% had significantly decreased leptin concentrations by 18% at 24 months (P < 0.01). A 4% increase in body weight or a 9% increase in FMI significantly increased intercellular adhesion molecule-1 (ICAM-1), tumour necrosis factor-α (TNF-α) and leptin concentrations in postmenopausal women at 24 months (P < 0.01).
Conclusions
Modest weight loss in postmenopausal women has a lowering effect on leptin concentrations over 24 months which may improve inflammatory status whilst modest weight gain increases ICAM-1, leptin and TNF-α, markers which are associated with a pro-inflammatory state and vascular complications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013. https://doi.org/10.1155/2013/139239
Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. J Parenter Enteral Nutr. 2004;28:410–5.
Pardina E, Ferrer R, Baena-Fustegueras JA, Lecube A, Fort JM, Vargas V, et al. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg. 2010;20:623–32.
Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83.
Manigrasso MR, Ferroni P, Santilli F, Taraborelli T, Guagnano MT, Michetti N, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab. 2005;90:5876–9.
Trayhurn P. Adipose tissue in obesity - an inflammatory issue. Endocrinol. 2005;146:1003–5.
Després JP. Body fat distribution and risk of cardiovascular disease. Circulation. 2012;126:1301–13.
Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106:S5–S78.
Pérez de Heredia F, Gómez-Martínez S, Marcos A. Chronic and degenerative diseases. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012;71:332–8.
Wells JCK, Fewtrell MS. Measuring body composition. Arch Dis Child. 2006;91:612–7.
Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in body fat distribution. Ann N Y Acad Sci. 2000;904:502–6.
Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med. 1995;123:673–5.
Lee K, Lee S, Kim YJ, Kim YJ. Waist circumference, dual-energy X-ray absorptiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition. 2008;24:625–31.
Lavoie ME, Rabasa-Lhoret R, Doucet É, Mignault D, Messier L, Bastard JP, et al. Association between physical activity energy expenditure and inflammatory markers in sedentary overweight and obese women. Int J Obes. 2010;34:1387–95.
Milewicz A, Jędrzejuk D, Dunajska K, Lwow F. Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women. Maturitas. 2010;65:272–5.
Siervo M, Prada CM, Mire E, Broyles S, Wells JCK, Heymsfield S, et al. Body composition indices of a load-capacity model: gender- and BMI-specific reference curves. Pub Health Nutr. 2014;18:1245–54.
Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105:804–9.
Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term resistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365:1597–604.
Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815–9.
Fogarty AW, Glancy C, Jones S, Lewis SA, McKeever TM, Britton JR. A prospective study of weight change and systemic inflammation over 9 y. Am J Clin Nutr. 2008;87:30–35.
Slevin MM, Allsopp PJ, Magee PJ, Bonham MP, Naughton VR, Strain JJ, et al. Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women. J Nutr. 2014;144:297–304.
Hagströmer M, Oja P, Sjöström M. The international physical activity questionnaire (IPAQ): a study of concurrent and construct validity. Pub Health Nutr. 2006;9:755–62.
World Health Organization. Obesity: Preventing and Managing the Global Epidemic. http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/ (accessed 8 November 2015).
Rolland YM, Perry HM 3rd, Patrick P, Banks WA, Morley JE. Leptin and adiponectin levels in middle-aged postmenopausal women: associations with lifestyle habits, hormones, and inflammatory markers--a cross-sectional study. Metabolism. 2006;55:1630–6.
Solin MS, Ball MJ, Robertson I, de Silva A, Pasco JA, Kotowicz MA, et al. Relationship of serum leptin to total and truncal body fat. Clin Sci. 1997;93:581–4.
Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:137–44.
Ryan AS, Nicklas BJ, Berman DM, Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord. 2003;27:1066–71.
Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, et al. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol. 2008;158:179–87.
Shamsuzzaman AS, Winnicki M, Wolk R, Svatikova A, Phillips BG, Davison DE, et al Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation. 2004;109:2181–5.
Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001;104:3052–6.
Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008;21:117–33.
Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88–92.
Demerath E, Towne B, Blangero J, Siervogel RM. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann Hum Biol. 2001;28:664–78.
Acknowledgements
This work was supported by Marigot (Cork, Ireland), Ingredion Inc. (Bridgewater, NJ) and the Department for Employment and Learning.
Author information
Authors and Affiliations
Contributions
BEC conducted the laboratory analysis; BEC and EMM were involved in the statistical analysis; and BEC, PJA, MMS, PJM, TAM, MBEL, JJS and EMM were involved in data interpretation. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Cronin, B.E., Allsopp, P.J., Slevin, M.M. et al. The effect of weight change over a 2-year period on inflammatory status in postmenopausal women. Eur J Clin Nutr 72, 388–393 (2018). https://doi.org/10.1038/s41430-017-0014-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-017-0014-9